230 related articles for article (PubMed ID: 18704164)
1. Crystal structure of botulinum neurotoxin type A in complex with the cell surface co-receptor GT1b-insight into the toxin-neuron interaction.
Stenmark P; Dupuy J; Imamura A; Kiso M; Stevens RC
PLoS Pathog; 2008 Aug; 4(8):e1000129. PubMed ID: 18704164
[TBL] [Abstract][Full Text] [Related]
2. The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction.
Rummel A; Mahrhold S; Bigalke H; Binz T
Mol Microbiol; 2004 Feb; 51(3):631-43. PubMed ID: 14731268
[TBL] [Abstract][Full Text] [Related]
3. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F.
Fu Z; Chen C; Barbieri JT; Kim JJ; Baldwin MR
Biochemistry; 2009 Jun; 48(24):5631-41. PubMed ID: 19476346
[TBL] [Abstract][Full Text] [Related]
4. Gangliosides interact with synaptotagmin to form the high-affinity receptor complex for botulinum neurotoxin B.
Flores A; Ramirez-Franco J; Desplantes R; Debreux K; Ferracci G; Wernert F; Blanchard MP; Maulet Y; Youssouf F; Sangiardi M; Iborra C; Popoff MR; Seagar M; Fantini J; Lévêque C; El Far O
Proc Natl Acad Sci U S A; 2019 Sep; 116(36):18098-18108. PubMed ID: 31431523
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co-receptor ganglioside.
Gregory KS; Liu SM; Acharya KR
FEBS Open Bio; 2020 Mar; 10(3):298-305. PubMed ID: 31945264
[TBL] [Abstract][Full Text] [Related]
6. Conformational analysis of GT1B ganglioside and its interaction with botulinum neurotoxin type B: a study by molecular modeling and molecular dynamics.
Venkateshwari S; Veluraja K
J Biomol Struct Dyn; 2012; 30(3):255-68. PubMed ID: 22746533
[TBL] [Abstract][Full Text] [Related]
7. Structure of dual receptor binding to botulinum neurotoxin B.
Berntsson RP; Peng L; Dong M; Stenmark P
Nat Commun; 2013; 4():2058. PubMed ID: 23807078
[TBL] [Abstract][Full Text] [Related]
8. Crystal Structures of Botulinum Neurotoxin Subtypes A4 and A5 Cell Binding Domains in Complex with Receptor Ganglioside.
Gregory KS; Mojanaga OO; Liu SM; Acharya KR
Toxins (Basel); 2022 Feb; 14(2):. PubMed ID: 35202156
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the botulinum neurotoxin type G binding domain: insight into cell surface binding.
Stenmark P; Dong M; Dupuy J; Chapman ER; Stevens RC
J Mol Biol; 2010 Apr; 397(5):1287-97. PubMed ID: 20219474
[TBL] [Abstract][Full Text] [Related]
10. Structural and Biochemical Characterization of Botulinum Neurotoxin Subtype B2 Binding to Its Receptors.
Davies JR; Masuyer G; Stenmark P
Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32957706
[TBL] [Abstract][Full Text] [Related]
11. Characterization of clostridium botulinum neurotoxin serotype A (BoNT/A) and fibroblast growth factor receptor interactions using novel receptor dimerization assay.
James NG; Malik S; Sanstrum BJ; Rhéaume C; Broide RS; Jameson DM; Brideau-Andersen A; Jacky BS
Sci Rep; 2021 Apr; 11(1):7832. PubMed ID: 33837264
[TBL] [Abstract][Full Text] [Related]
12. Differential contribution of the residues in C-terminal half of the heavy chain of botulinum neurotoxin type B to its binding to the ganglioside GT1b and the synaptotagmin 2/GT1b complex.
Kohda T; Ihara H; Seto Y; Tsutsuki H; Mukamoto M; Kozaki S
Microb Pathog; 2007; 42(2-3):72-9. PubMed ID: 17188834
[TBL] [Abstract][Full Text] [Related]
13. Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B.
Swaminathan S; Eswaramoorthy S
Nat Struct Biol; 2000 Aug; 7(8):693-9. PubMed ID: 10932256
[TBL] [Abstract][Full Text] [Related]
14. Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins.
Kozaki S; Kamata Y; Watarai S; Nishiki T; Mochida S
Microb Pathog; 1998 Aug; 25(2):91-9. PubMed ID: 9712688
[TBL] [Abstract][Full Text] [Related]
15. Glycans Confer Specificity to the Recognition of Ganglioside Receptors by Botulinum Neurotoxin A.
Hamark C; Berntsson RP; Masuyer G; Henriksson LM; Gustafsson R; Stenmark P; Widmalm G
J Am Chem Soc; 2017 Jan; 139(1):218-230. PubMed ID: 27958736
[TBL] [Abstract][Full Text] [Related]
16. Unique ganglioside recognition strategies for clostridial neurotoxins.
Benson MA; Fu Z; Kim JJ; Baldwin MR
J Biol Chem; 2011 Sep; 286(39):34015-22. PubMed ID: 21849494
[TBL] [Abstract][Full Text] [Related]
17. The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.
Ayyar BV; Aoki KR; Atassi MZ
Infect Immun; 2015 Apr; 83(4):1465-76. PubMed ID: 25624352
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of Ganglioside Receptor Recognition by Botulinum Neurotoxin Serotype E.
Masuyer G; Davies JR; Stenmark P
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361086
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a membrane binding loop leads to engineering botulinum neurotoxin B with improved therapeutic efficacy.
Yin L; Masuyer G; Zhang S; Zhang J; Miyashita SI; Burgin D; Lovelock L; Coker SF; Fu TM; Stenmark P; Dong M
PLoS Biol; 2020 Mar; 18(3):e3000618. PubMed ID: 32182233
[TBL] [Abstract][Full Text] [Related]
20. Botulinum neurotoxin A changes conformation upon binding to ganglioside GT1b.
Yowler BC; Schengrund CL
Biochemistry; 2004 Aug; 43(30):9725-31. PubMed ID: 15274627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
